OMEGA THERAPEUTICS INC. - COMMON STOCK

Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC

16 10 2023 07:00:46 提供 Nasdaq GlobeNewswire

Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023

11 10 2023 16:00:14 提供 Nasdaq GlobeNewswire

Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

04 10 2023 16:00:05 提供 Nasdaq GlobeNewswire

Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial

26 9 2023 07:00:11 提供 Nasdaq GlobeNewswire

Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26

25 9 2023 16:00:32 提供 Nasdaq GlobeNewswire

Omega Therapeutics to Participate in Two Upcoming Investor Conferences

21 9 2023 16:00:08 提供 Nasdaq GlobeNewswire

Omega Therapeutics Announces Updates to its Board of Directors

29 8 2023 07:00:52 提供 Nasdaq GlobeNewswire

Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress

03 8 2023 16:00:00 提供 Nasdaq GlobeNewswire

Omega Therapeutics Appoints Chris Schade to its Board of Directors

12 7 2023 07:00:36 提供 Nasdaq GlobeNewswire

Omega Therapeutics to Participate in Two Upcoming Investor Conferences

01 6 2023 07:00:12 提供 Nasdaq GlobeNewswire

Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers™ to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting

31 5 2023 07:00:18 提供 Nasdaq GlobeNewswire

Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress

04 5 2023 07:00:07 提供 Nasdaq GlobeNewswire

Omega Therapeutics to Present New Preclinical Data at the American Society of Clinical Oncology 2023 Annual Meeting

27 4 2023 07:00:31 提供 Nasdaq GlobeNewswire

Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma

30 3 2023 07:00:49 提供 Nasdaq GlobeNewswire

Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

01 3 2023 07:00:14 提供 Nasdaq GlobeNewswire

Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock

23 2 2023 07:00:51 提供 Nasdaq GlobeNewswire

Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium

17 1 2023 07:00:13 提供 Nasdaq GlobeNewswire